Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Regulatory barriers to tissue-engineered products.

E Schutte1

  • 1IsoTis NV, Bilthoven, The Netherlands. eliane.schutte@isotis.com

Medical Device Technology
|May 3, 2002
PubMed
Summary

Autologous tissue engineering harnesses the body's regenerative power for medical treatments. However, a lack of European Union regulation threatens the future of these advanced cellular and tissue-based products in Europe.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Intraocular pressure after extracapsular cataract extraction with posterior chamber lens implantation--sulcus versus capsular bag fixation].

Klinische Monatsblatter fur Augenheilkunde·1997
Same author

[Modified radiation administration in Er:YAG laser ab externo sclerostomy].

Klinische Monatsblatter fur Augenheilkunde·1997
Same author

[Ab externo sclerostomy with the Er:YAG laser: report of outcome after 2 years].

Klinische Monatsblatter fur Augenheilkunde·1996
Same author

Evaluation of intraocular pressure with Healon and Healon GV in sutureless cataract surgery with foldable lens implantation.

Journal of cataract and refractive surgery·1996
Same author

[Congenital familial cornea plana with ptosis, peripheral sclerocornea and conjunctival xerosis].

Klinische Monatsblatter fur Augenheilkunde·1995
Same author

[Postoperative intraocular pressure in the first days after intraocular administration of hyaluronic acid solution with different viscosities].

Klinische Monatsblatter fur Augenheilkunde·1995

Area of Science:

  • Biomedical Engineering
  • Regenerative Medicine
  • Cellular Therapy

Background:

  • Autologous tissue-engineering utilizes the body's inherent regenerative capabilities for clinical applications.
  • Human cellular- and tissue-based products offer therapeutic solutions for repair, reproduction, and replacement.
  • Current regulatory frameworks in Europe do not adequately address these advanced medical products.

Purpose of the Study:

  • To highlight the potential of autologous tissue engineering.
  • To discuss the scope of human cellular- and tissue-based products.
  • To address the critical issue of regulatory gaps in the European Union.

Main Methods:

  • Review of current autologous tissue-engineering technologies.
  • Analysis of the applications of human cellular- and tissue-based products.
  • Examination of the European Union's regulatory landscape for regenerative medicine.

Main Results:

  • Autologous tissue engineering shows significant promise for various clinical needs.
  • A diverse range of cellular and tissue products are available for therapeutic use.
  • The absence of specific EU regulations poses a substantial risk to the field's advancement.

Conclusions:

  • Autologous tissue engineering is a vital area of medical innovation.
  • Standardized EU regulation is essential for the safe and effective deployment of these products.
  • Addressing the regulatory deficit is crucial for the future viability of tissue engineering in Europe.

Related Experiment Videos